These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19649598)

  • 21. Peptide array-based interaction assay of solid-bound peptides and anchorage-dependant cells and its effectiveness in cell-adhesive peptide design.
    Kato R; Kaga C; Kunimatsu M; Kobayashi T; Honda H
    J Biosci Bioeng; 2006 Jun; 101(6):485-95. PubMed ID: 16935250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the essential collective dynamics of interacting proteins: application to prion protein dimers.
    Issack BB; Berjanskii M; Wishart DS; Stepanova M
    Proteins; 2012 Jul; 80(7):1847-65. PubMed ID: 22488640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propagation of ovine prions from "poor" transmitter scrapie isolates in ovine PrP transgenic mice.
    Thackray AM; Hopkins L; Lockey R; Spiropoulos J; Bujdoso R
    Exp Mol Pathol; 2012 Feb; 92(1):167-74. PubMed ID: 22120785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of humic substances with the human prion protein fragment 90-231 affects its protease K resistance and cell internalization.
    Corsaro A; Anselmi C; Polano M; Aceto A; Florio T; De Nobili M
    J Biol Regul Homeost Agents; 2010; 24(1):27-39. PubMed ID: 20385069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparate evolution of prion protein domains and the distinct origin of Doppel- and prion-related loci revealed by fish-to-mammal comparisons.
    Rivera-Milla E; Oidtmann B; Panagiotidis CH; Baier M; Sklaviadis T; Hoffmann R; Zhou Y; Solis GP; Stuermer CA; Málaga-Trillo E
    FASEB J; 2006 Feb; 20(2):317-9. PubMed ID: 16352647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.
    Pillot T; Lins L; Goethals M; Vanloo B; Baert J; Vandekerckhove J; Rosseneu M; Brasseur R
    J Mol Biol; 1997 Dec; 274(3):381-93. PubMed ID: 9405147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying protein-protein interaction sites using peptide arrays.
    Amartely H; Iosub-Amir A; Friedler A
    J Vis Exp; 2014 Nov; (93):e52097. PubMed ID: 25490271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.
    Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS
    J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of prion protein (PrP) by RNA interference weakens the protective activity of wild-type PrP against copper ion and antagonizes the cytotoxicity of fCJD-associated PrP mutants in cultured cells.
    Wang ZY; Tian C; Jing YY; Gong HS; Guo Y; Shi Q; Chen C; Zhu SY; Dong XP
    Int J Mol Med; 2011 Sep; 28(3):413-21. PubMed ID: 21537833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide NMHRYPNQ of the cellular prion protein (PrP(C)) inhibits aggregation and is a potential key for understanding prion-prion interactions.
    Rehders D; Claasen B; Redecke L; Buschke A; Reibe C; Jehmlich N; von Bergen M; Betzel C; Meyer B
    J Mol Biol; 2009 Sep; 392(1):198-207. PubMed ID: 19607841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
    Uppington KM; Brown DR
    J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.
    Lau AL; Yam AY; Michelitsch MM; Wang X; Gao C; Goodson RJ; Shimizu R; Timoteo G; Hall J; Medina-Selby A; Coit D; McCoin C; Phelps B; Wu P; Hu C; Chien D; Peretz D
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11551-6. PubMed ID: 17601775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prion protein region 23-32 interacts with tubulin and inhibits microtubule assembly.
    Osiecka KM; Nieznanska H; Skowronek KJ; Karolczak J; Schneider G; Nieznanski K
    Proteins; 2009 Nov; 77(2):279-96. PubMed ID: 19422054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Theoretical study of the prion protein based on the fragment molecular orbital method.
    Ishikawa T; Ishikura T; Kuwata K
    J Comput Chem; 2009 Dec; 30(16):2594-601. PubMed ID: 19408278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein.
    Schmitt-Ulms G; Legname G; Baldwin MA; Ball HL; Bradon N; Bosque PJ; Crossin KL; Edelman GM; DeArmond SJ; Cohen FE; Prusiner SB
    J Mol Biol; 2001 Dec; 314(5):1209-25. PubMed ID: 11743735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical biology of prion protein: tools to bridge the in vitro/vivo interface.
    Seidel R; Engelhard M
    Top Curr Chem; 2011; 305():199-223. PubMed ID: 21769714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of antibodies against bovine recombinant prion protein in various strains of mice.
    Andrievskaia O; McRae H; Elmgren C; Huang H; Balachandran A; Nielsen K
    Clin Vaccine Immunol; 2006 Jan; 13(1):98-105. PubMed ID: 16426006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biosensing of lipid-prion interactions: insights on charge effect, Cu(II)-ions binding and prion oligomerization.
    Steunou S; Chich JF; Rezaei H; Vidic J
    Biosens Bioelectron; 2010 Dec; 26(4):1399-406. PubMed ID: 20692152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strain-specific effects of reducing agents on the cell-free conversion of recombinant prion protein into a protease-resistant form.
    Imamura M; Kato N; Okada H; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T
    Microbiol Immunol; 2011 Sep; 55(9):633-40. PubMed ID: 21645053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.